Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

Magnetic Resonance Imaging, Intestine Small, Crohn Disease. Clinical Trial

Official title:

MRI of the Small Bowel. Comparison of Different Techniques and Contrast.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00204165
• Other study ID #: 431-04150
• Status: Active, not recruiting
• Phase: Phase 3
• First received: September 13, 2005
• Last updated: September 7, 2006
• Start date: November 2004
• Est. completion date: June 2005

Study information

• Verified date: September 2006
• Source: University of Oslo
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Directorate of Health
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 40
• Est. completion date: June 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• above 18 years

• known Crohns disease or strong suspicion.

• need of a small bowel examination

Exclusion Criteria:

• pregnant

• electrolyte disturbances.

• Any MRI contraindications.

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Crohn Disease
• Magnetic Resonance Imaging, Intestine Small, Crohn Disease.

Intervention

Procedure:
• MRI of the small bowel

Locations

Country	Name	City	State
Norway	Ulleval Universitets sykehus	Kirkeveien 166	Oslo

Sponsors (1)

Lead Sponsor	Collaborator
University of Oslo

Country where clinical trial is conducted

Norway,